Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 20 Oct 2021

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer

in Thoracic Oncology

Qiaxuan Li
Lintong Yao
Zenan Lin
Fasheng Li
Daipeng Xie
Congsen Li
Weijie Zhan
Weihuan Lin
Luyu Huang
Shaowei Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.706616

3,547 views
1 citation

Original Research

Published on 20 Oct 2021

Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib

in Thoracic Oncology

Yu Wang
Songtao Liu
Alei Feng
Huan Luo
Jinwei Hu
Kai Wang
Wei Dong

Frontiers in Oncology

doi 10.3389/fonc.2021.727312

4,106 views
2 citations

Systematic Review

Published on 12 Oct 2021

Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review

in Thoracic Oncology

Jatta Saarenheimo
Heidi Andersen
Natalja Eigeliene
Antti Jekunen

Frontiers in Oncology

doi 10.3389/fonc.2021.754427

4,209 views
11 citations

Mini Review

Published on 11 Oct 2021

Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice

in Thoracic Oncology

Pierre Loap
Viviana Vitolo
Amelia Barcellini
Ludovic De Marzi
Alfredo Mirandola
Maria Rosaria Fiore
Barbara Vischioni
Barbara Alicja Jereczek-Fossa
Nicolas Girard
Youlia Kirova

Frontiers in Oncology

doi 10.3389/fonc.2021.738320

2,991 views
2 citations

Original Research

Published on 08 Oct 2021

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy

in Thoracic Oncology

Lingling Li
Chenghui Pi
Xin Yan
Jiangyue Lu
Xuhui Yang
Chunyu Wang
Xiaoyan Li
Sujie Zhang
Zhibo Zhang
Yi Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.697865

10,882 views
25 citations

Original Research

Published on 08 Oct 2021

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients

in Thoracic Oncology

Jing Qi
Jiaqi Zhang
Xingping Ge
Xin Wang
Liming Xu
Ningbo Liu
Lujun Zhao
Ping Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.713014

4,171 views
22 citations

Original Research

Published on 06 Oct 2021

The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma

in Thoracic Oncology

Naoki Yanagawa
Noriyuki Yamada
Ryo Sugimoto
Mitsumasa Osakabe
Noriyuki Uesugi
Satoshi Shiono
Makoto Endoh
Shin-ya Ogata
Hajime Saito
Makoto Maemondo

Frontiers in Oncology

doi 10.3389/fonc.2021.752005

3,714 views
13 citations

Original Research

Published on 06 Oct 2021

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival

in Thoracic Oncology

Lihua Liu
Hongliang Liu
Sheng Luo
Edward F. Patz
Carolyn Glass
Li Su
Lijuan Lin
David C. Christiani
Qingyi Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.717109

4,132 views
7 citations

Original Research

Published on 06 Oct 2021

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

in Thoracic Oncology

Yan Hu
Si-Ying Ren
Ruo-Yao Wang
Chao Zeng
Ji-Na Li
Peng Xiao
Fang Wu
Feng-Lei Yu
Wen-Liang Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.684070

7,192 views
16 citations

Original Research

Published on 01 Oct 2021

Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Ming Yang
Lingling Tan
Lingling Xie
Song Hu
Dan Liu
Jing Wang
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2021.754975

4,498 views
15 citations

Original Research

Published on 29 Sep 2021

Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations

in Thoracic Oncology

Jiatao Liao
Chang Liu
Qianqian Long
Xianghua Wu
Huijie Wang
Hui Yu
Si Sun
Yao Zhang
Ying Lin
Xinmin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.752545

5,838 views
6 citations

Original Research

Published on 28 Sep 2021

A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma

in Thoracic Oncology

Kai Wang
Man Zhang
Jiao Wang
Pan Sun
Jizhuang Luo
Haizhen Jin
Rong Li
Changqing Pan
Liming Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.737152

6,752 views
13 citations

Original Research

Published on 28 Sep 2021

Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma

in Thoracic Oncology

Minjun Du
Yicheng Liang
Zixu Liu
Xingkai Li
Mei Liang
Boxuan Zhou
Yushun Gao

Frontiers in Oncology

doi 10.3389/fonc.2021.693353

6,407 views
13 citations

Original Research

Published on 24 Sep 2021

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

in Thoracic Oncology

Toshiya Fujisaki
Satoshi Watanabe
Takeshi Ota
Kohei Kushiro
Yusuke Sato
Miho Takahashi
Aya Ohtsubo
Satoshi Shoji
Koichiro Nozaki
Kosuke Ichikawa

Frontiers in Oncology

doi 10.3389/fonc.2021.704475

5,879 views
24 citations

Original Research

Published on 24 Sep 2021

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma

in Thoracic Oncology

Jia Li
Huahua Li
Chenyue Zhang
Chenxing Zhang
Lifeng Jiang
Haiyong Wang
Huaimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.732841

3,312 views
3 citations

Original Research

Published on 24 Sep 2021

Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population

in Thoracic Oncology

Chunqiu Xia
Minghui Liu
Xin Li
Hongbing Zhang
Xuanguang Li
Di Wu
Dian Ren
Yu Hua
Ming Dong
Hongyu Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.700179

3,796 views
7 citations

Original Research

Published on 23 Sep 2021

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer

in Thoracic Oncology

Di Li
Chaoqiang Deng
Qiang Zheng
Fangqiu Fu
Shengping Wang
Yuan Li
Haiquan Chen
Yang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.704517

4,233 views
5 citations

Original Research

Published on 22 Sep 2021

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

in Thoracic Oncology

Yanan Wang
Fangfei Qian
Ya Chen
Zhengyu Yang
Minjuan Hu
Jun Lu
Yanwei Zhang
Wei Zhang
Lei Cheng
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.714549

4,992 views
7 citations

Original Research

Published on 21 Sep 2021

Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs

in Thoracic Oncology

Xin Wang
Manqi Wu
Haifeng Shen
Yuntao Nie
Kai Zhang
Zihan Wei
Ziyang Wang
Fan Yang
Kezhong Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.725475

4,564 views
6 citations

Original Research

Published on 17 Sep 2021

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients

in Thoracic Oncology

Foteinos-Ioannis D. Dimitrakopoulos
Anna G. Antonacopoulou
Anastasia E. Kottorou
Melpomeni Kalofonou
Nikolaos Panagopoulos
Dimitrios Dougenis
Thomas Makatsoris
Vasiliki Tzelepi
Angelos Koutras
Haralabos P. Kalofonos

Frontiers in Oncology

doi 10.3389/fonc.2021.721577

3,118 views
3 citations

Original Research

Published on 15 Sep 2021

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer

in Thoracic Oncology

Xianghan Li
Yiran Zou
Teng Li
Thomas K. F. Wong
Ryan T. Bushey
Michael J. Campa
Elizabeth B. Gottlin
Hongliang Liu
Qingyi Wei
Allen Rodrigo

Frontiers in Oncology

doi 10.3389/fonc.2021.709829

3,921 views
13 citations

Original Research

Published on 15 Sep 2021

Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter Study

in Thoracic Oncology

Zhe Ji
Bin Huo
Shifeng Liu
Qinghua Liang
Chao Xing
Miaomiao Hu
Yanli Ma
Zhe Wang
Xinxin Zhao
Yuqing Song

Frontiers in Oncology

doi 10.3389/fonc.2021.706242

3,831 views
9 citations

Systematic Review

Published on 13 Sep 2021

Molecular Alterations in Lung Adenocarcinoma With Ground-Glass Nodules: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Zihan Wei
Ziyang Wang
Yuntao Nie
Kai Zhang
Haifeng Shen
Xin Wang
Manqi Wu
Fan Yang
Kezhong Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.724692

7,184 views
10 citations

Systematic Review

Published on 13 Sep 2021

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer

in Thoracic Oncology

Panpan Jiang
Ziyang Mao
Qinyang Wang
Xiaohui Jia
Luying Geng
Hong Xu
Lili Jiang
Chengcheng Yang
Min Jiao
Hui Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.698199

10,354 views
9 citations

1,969 articles

articles

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer

Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib

Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review

Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients

The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer

Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations

A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma

Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma

Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer

Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter Study

Molecular Alterations in Lung Adenocarcinoma With Ground-Glass Nodules: A Systematic Review and Meta-Analysis

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer